Corrigendum to "Blend to Limit OxygEN in ECMO: A RanDomised ControllEd Registry (BLENDER) trial: Study protocol and statistical analysis plan" [Crit Care Resuscit 25 (2023) 118-125]
Crit Care Resusc. 2024 Feb 1;26(1):60.
doi: 10.1016/j.ccrj.2024.01.003.
eCollection 2024 Mar.
1 Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
2 Department of Intensive Care and Hyperbaric Medicine, The Alfred, Melbourne, VIC, Australia.
3 Department of Critical Care, School of Medicine, University of Melbourne, VIC, Australia.
4 St. Vincent's Hospital Sydney, University of New South Wales, Darlinghurst, NSW, Australia.
5 Critical Care Research Group, Brisbane, QLD, Australia.
6 Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
7 Intensive Care Unit, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
8 Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
9 Data Analytics Research and Evaluation (DARE) Centre, Austin Hospital, Melbourne, VIC, Australia.
10 Department of Anaesthetics, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
11 Adult Intensive Care Unit, The Prince Charles Hospital, Brisbane, QLD, Australia.
12 Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
13 Intensive Care Unit, Fiona Stanley Hospital, Murdoch, WA, Australia.
14 Intensive Care Unit, St Vincent's Hospital, Darlinghurst, NSW, Australia.
15 Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, VIC, Australia.
16 School of Medicine, Deakin University, Waurn Ponds, VIC, Australia.